# Pemetrexed

NDC: 0480-4516
Generic name: Pemetrexed
Labeler / Manufacturer: Teva Pharmaceuticals, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: SOLUTION, CONCENTRATE
Routes: INTRAVENOUS
Marketing started: 20220601

FDA application: NDA208419

## Active ingredients

- PEMETREXED MONOHYDRATE: 25 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0480-4516"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0480-4516
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=8b660f68-b770-4e0a-b2f9-25e663deecc3